Physician

Allan X. Zhang, DO

According to 2025 Medicare claims, Allan Zhang, DO (NPI: 1811301021) practices diagnostic radiology in the Cape Coral-Fort Myers, FL market, with the plurality of this provider's patient population coming from Lee, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 33908-4156. Zhang is affiliated with the SOMOS ACO (ACO ID: A4577) and ilumed, LLC (ACO ID: D0005), participating under both the MSSP and REACH models.

Zhang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 667 traditional Medicare patients, billed 3,283 HCPCS/CPT codes, and received $211,613 in Medicare payments. The top billing code was 64493 (Injection of lower or sacral spine facet joint using imaging guidance, single level). Part D data shows 1,016 prescription claims across 270 beneficiaries totaling $74,981 in drug costs, led by Diclofenac Epolamine (Diclofenac Epolamine). Open Payments data shows 11 records totaling $399. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $5,339 to $74,981. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	129	872	$58,548
2022	1,093	2,352	$99,513
2023	1,305	2,609	$44,830
2024	667	3,283	$211,613

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	21	46	$5,339
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	42	82	$3,511
2021	120	301	$11,006
2022	77	232	$5,491
2023	80	142	$23,975
2024	270	1,016	$74,981

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64493	Injection of lower or sacral spine facet joint using imaging guidance, single level	33	45	$236
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	87	87	$152
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	419	796	$116
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	130	172	$82
74177	Ct scan of abdomen and pelvis with contrast	48	49	$73

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Diclofenac Epolamine	Diclofenac Epolamine	39	1,005	$22,833
Diclofenac Sodium	Diclofenac Sodium	93	2,749	$15,322
Xtampza Er	Oxycodone Myristate	21	630	$13,421
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	149	3,973	$3,044
Buprenorphine	Buprenorphine	12	336	$2,183

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$399	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Allan X. Zhang, DO?

Tedicare shows public-source Medicare data for Allan X. Zhang, DO (NPI 1811301021), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Allan X. Zhang, DO have ACO affiliation data?

Allan X. Zhang, DO is shown with ACO affiliation data for SOMOS ACO (MSSP, ACO ID A4577) and ilumed, LLC (REACH, ACO ID D0005).

What billing organization is linked to Allan X. Zhang, DO?

Allan X. Zhang, DO is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Allan X. Zhang, DO have Open Payments data?

Allan X. Zhang, DO has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.